Prof. Dr. Meral Beksaç

Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): Therapy induced changes and effects on survival

Leukemia and Lymphoma, 2004

DOI 10.1080/1042819032000159915 PMID 15359999 52 Zitationen (Europe PMC) Quelle: ORCID

Both higher level of (bcr,abl) transcripts and high Hasford risk score are associated with cytogenetic response but absence of molecular remission during first line use of imatinib mesilate(IM): A finding not observed following use among interferon failures

Blood, 2004

Quelle: ORCID

Case-controlled comparative analysis of ablative and reduced-intensity allogeneic haematopoietic stem cell transplantation in standard risk CML

Bone Marrow Transplantation, 2004

Quelle: ORCID

Does donor/recipient parity have any impact on graft-versus-host disease? The results of a single-centre retrospective multivariate analysis

Bone Marrow Transplantation, 2004

Quelle: ORCID

Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease

Transfusion and Apheresis Science, 2004

DOI 10.1016/j.transci.2004.02.003 PMID 15172621 32 Zitationen (Europe PMC) Quelle: ORCID

Factors influencing the outcome of HLA-identical sibling transplants for chronic myeloid leukaemia: collaborative analysis from three centres in Poland and Turkey

Bone Marrow Transplantation, 2004

Quelle: ORCID

High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre

Bone Marrow Transplantation, 2004

Quelle: ORCID

Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

Journal of Viral Hepatitis, 2004

DOI 10.1046/j.1365-2893.2003.00479.x PMID 14996349 60 Zitationen (Europe PMC) Quelle: ORCID

Occurrence of cytomegalovirus infection and/or viraemia shortens overall survival

Bone Marrow Transplantation, 2004

Quelle: ORCID

The comparison of myeloablative versus reduced intensity conditioning regimen in ABO mismatched allogeneic hematopoietic cell transplantation

Blood, 2004

Quelle: ORCID

The impact of HLA-dr antigens on chronic graft-versus-host disease associated oral lichenoid lesions

Bone Marrow Transplantation, 2004

Quelle: ORCID

The outcome of patients with an identified HLA identical sibling donor:: impact of transplantation rate on early transplant outcome

Bone Marrow Transplantation, 2004

Quelle: ORCID

The use of low molecular weight heparins (dalteparin) for prophylaxis against thromboembolic complications during allogeneic haematopoetic stem cell transplantation

Bone Marrow Transplantation, 2004

Quelle: ORCID

Akut Miyeloid Lösemi

2004

Quelle: OpenAlex

A retrospective comparison of oral versus intravenous administration of busulfan

Bone Marrow Transplantation, 2003

Quelle: ORCID

Allogeneic Hematopoietic Stem Cell Transplantation in chronic myelogenous leukemia: Comparison of ablative and reduced intensity conditioning regimen

Blood, 2003

Quelle: ORCID

Autologous platelet collection and storage to support thrombocytopenia in a leukemia patient with platelet alloimmunization undergoing chemotherapy

Turkish Journal of Haematology, 2003

PMID 27263520 1 Zitation (OpenAlex) Quelle: ORCID

Comparative analysis of molecular response following interferon-alpha, imatinib mesilate or allogeneic stem cell transplantation (ASCT): best response is obtained with ASCT in chronic myeloid leukemia

Bone Marrow Transplantation, 2003

Quelle: ORCID

Comparison of mobilized peripheral blood progenitor cells and bone marrow transplantation to HLA-identical siblings with standard-risk leukaemia: long term follow-up

Bone Marrow Transplantation, 2003

Quelle: ORCID

Comparison of three conditioning regimens used in high-dose therapy of malign lymphomas: CBV-ICE-CTM

Bone Marrow Transplantation, 2003

Quelle: ORCID

Differences between graft product and donor side effects following bone marrow or stem cell donation

Bone Marrow Transplantation, 2003

DOI 10.1038/sj.bmt.1704245 PMID 14561987 69 Zitationen (Europe PMC) Quelle: ORCID

Donor type epithelial cell repopulation in gastrointestinal mucosa following sex mismatch allogeneic peripheral blood transplantation: evidence for in vivo stem cell plasticity?

Bone Marrow Transplantation, 2003

Quelle: ORCID

Extracorporeal photoimmunotherapy for treatment of steroid refractory extensive chronic graft versus host disease:: Turkish experience

Bone Marrow Transplantation, 2003

Quelle: ORCID

Fetal-obstetric parameters that decrease volume (V) or mononuclear cell content (MNC) do not influence total hematopoietic cell content (HSCC) in the cord blood (CB) harvest

Blood, 2003

Quelle: ORCID

Hyperkeratosis of the Nipple Associated with Chronic Graft versus Host Disease after Allogeneic Haematopoietic Cell Transplantation [8]

Acta Dermato-Venereologica, 2003

DOI 10.1080/00015550310012665 PMID 14609115 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

In vitro binding and complement dependent cytotoxicity (CDC) of Rituximab(R) in patients with chronic B-lymphoproliferative disorders: Effects of glycosylphosphatidil inositol (GIP) expression and cyclosporin A (CsA)

Blood, 2003

Quelle: ORCID

Kinetics of chimerism in sex-mismatched allogeneic hematopoietic cell transplantation with reduced-intensity conditioning

Bone Marrow Transplantation, 2003

Quelle: ORCID

Long-term evaluation of hematopoietic and immune reconstitution following allogeneic peripheral blood hematopoietic cell transplantation during graft-versus-host disease

Bone Marrow Transplantation, 2003

Quelle: ORCID

Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

Blood, 2003

DOI 10.1182/blood-2003-03-0665 PMID 12829583 42 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Reduction of stem cell content is a feasible approach in standard risk HLA identical sibling allogeneic peripheral or marrow transplants

Bone Marrow Transplantation, 2003

Quelle: ORCID

Role of pretransplant interferon-α(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): Results from three Turkish transplant centers

Bone Marrow Transplantation, 2003

DOI 10.1038/sj.bmt.1703930 PMID 12748666 2 Zitationen (Europe PMC) Quelle: ORCID

The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemia

Leukemia and Lymphoma, 2003

DOI 10.1080/1042819031000067512 PMID 12802915 6 Zitationen (Europe PMC) Quelle: ORCID

The effect of hepatitis B virus status of donor on the hepatitis B virus serology of recipient after allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation, 2003

Quelle: ORCID

The effect of hepatitis B virus status of the donor on the hepatitis B virus serology of the recipient after allogeneic hematopoietic cell transplantation

Journal of Hepatology, 2003

DOI 10.1016/s0168-8278(03)80768-7 Quelle: ORCID

The effect of mycophenolate mofetil in steroid refractory or dependent chronic graft-versus-host disease

Bone Marrow Transplantation, 2003

Quelle: ORCID

The highest doses of alkylating agents administered during hematopoietic stem cell transplantation

Bone Marrow Transplantation, 2003

Quelle: ORCID

The relation between T-helper subsets and the risk of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation, 2003

Quelle: ORCID

Tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), interleukin-10 (IL-10), transforming growth factor-beta (TGF-beta) and interferon-gamma (INF-gamma) polymorphic single nucleotide allele frequencies in patients with multiple myeloma (MM): Disparities between the siblings and effect on treatment outcome

Blood, 2003

Quelle: ORCID

Feature extraction and classification of blood cells for an automated differential blood count system

International Joint Conference on Neural Networks (IJCNN), 2002

DOI 10.1109/ijcnn.2001.938753 72 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

A retrospective comparison of oral versus intravenous administration of Busulfan: Preliminary results show similar toxicity but less relapse

Bone Marrow Transplantation, 2002

Quelle: ORCID

Analysis of high and low risk chronic myeloid leukemia by gene expression profiling

Blood, 2002

Quelle: ORCID

Does donor recipient ABO-incompatibility have any effect on the course and outcome of allogeneic hematopoietic cell transplantation?

Bone Marrow Transplantation, 2002

Quelle: ORCID

Extramedullary presentation of biclonal IgGκ and IgAκ multiple myeloma

Turkish Journal of Haematology, 2002

PMID 27264980 1 Zitation (OpenAlex) Quelle: ORCID

HLA-A1 is associated with CMV viremia in recipients of hematopoietic stem cell transplants from seropositive donors

Tissue Antigens, 2002

Quelle: ORCID

In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia

Medical Oncology, 2002

DOI 10.1385/mo:19:1:59 PMID 12025892 6 Zitationen (Europe PMC) Quelle: ORCID

Influence of storage time on activation of platelets collected with CS 3000 Plus and Cobe Spectra using platelet storage containers

Therapeutic Apheresis, 2002

DOI 10.1046/j.1526-0968.2002.00319.x PMID 11886581 4 Zitationen (Europe PMC) Quelle: ORCID

Is there a correlation between peripheral blood CD34+cells and peripheral blood erythrocyte precursors in healthy G-CSF stimulated donors and the effect of G-CSF and apheresis on complete blood count

Bone Marrow Transplantation, 2002

Quelle: ORCID

Late non-relapse mortality after allogeneic hematopoietic cell transplantation: the impact of bronchiolitis obliterans

Bone Marrow Transplantation, 2002

Quelle: ORCID

Molecular response rates achieved in chronic myelogenous leukemia (CML) patients treated with interferon, imatinib mesylate (STI) or stem cell transplantation.: A single institutional experience

Blood, 2002

Quelle: ORCID

Outcome is worse in male compared to female de novo AML patients and can be improved with the use of granulocyte colony stimulating factor(G-CSF) during induction.: Results of a randomized multicentric Trial(Turkish leukemia study group (TLG95-002)

Blood, 2002

Quelle: ORCID